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by William D. Heizer*
Adultseating a Western diet digest and absorb ingested food containing approximately 100 g fat, 350 g
carbohydrate, and 75 g protein daily. Normal fat absorption requires adequate gastric, pancreatic,
liver-biHary, mucosal, and lymphatic function. Carbohydrate and protein absorption is much less depen-
dent on liver-billary and lymphatic function. The intestine has a large reserve capacity for digestion and
absorptionofnutrientswhichIsduetobothexcessfunctionandtoadaptivechangeswhichincreasefunction
Inonesegmentofthedigestive-absorptive system whenItIsdecreasedorlostinanother segment. Thelarge
reserve capacit exps why most of the prevalent intestinal diseases seldom cause clinically detectable
changes in absorption. However, there are more than 30 less-common human diseases which cause
malabsorption ofone or more nutrients. Those that cause the malabsorption syndrome, i.e., steatorrhea
andweight oss,canbeconveniently categorized according tothemajordeficiency leadingtotheabsorptive
defectasfollows:insufficientpancreaticenzymeactivity,insufficientbileacid, diseaseofthesmallintestinal
wail, multiple defects, mechanism unknown, and drug-induced malabsorption. A few diseases, most of
whiharecongenital, causemalabsorptionofonlyone orafewrelatednutrientssuch aslactosemalabsorp-
ton in lactase defciency. Most of the tests currently in use for detecting and diagnosing the cause of
malabsorption are relatively insensitive and nonspecific. Chemical analysis ofthe fat in a three-day stool
olnlection remains thesingle best test for diagnosing the malabsorption syndrome. However, a breath test
using Triolein labeled with either the radioactive or stable isotope ofcarbon may be an important recent
advance.Otherbreathtestsarealsocurrently beinginvestigated forquantitating absorptionormalabsorp-
tion ofvarious substances including bile acids and various sugars. Studies ofthe fumction ofthe intestinal
epthellalcellsareusually bestaccomplished usingtissueobtained by peroralbiopsy. Biopsy specimensare
usedformanytypesofstudyincludinglightandelectron microscopicexamination, chemicalandenzymatic
asays, tissue culture, and uptake of various radiolabeled compounds.
Absorptionofnutrients isthemajorfunctionofthe
gastrointestinal system. Although the most preva-
lent gastrointestinal diseases such as peptic ulcer,
cancers, and gallstones seldom cause clinically de-
tectable changes in absorption, there are more than
30 less common human diseases which do cause
malabsorption ofone or more nutrients (1, 2). These
diseases and the clinical methods used to evaluate
intestinal absorption will be reviewed.
The approximate amounts ofvarious nutrients in-
gested by normal adult Americans is shown in Table
1 (3). In addition, endogenous secretions must be
digested and absorbed, and they contribute about
6500ml ofwater, 35 to 100gprotein, andpossibly 20
to 30 g fat each day.
Table 2 summarizes the steps in digestion and
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absorption offats, carbohydrates and proteins. For
the sake of brevity, important gastric functions are
not shown. Pancreatic lipase assisted by colipase, a
low molecular weight protein which is also secreted
by the pancreas, hydrolyzes ingested triglyceride
predominantly to free fatty acids and /8-mono-
glyceride (4). This mixture is solubilized to a clear
micellarsolution bytheactionofbileacids(5, 6). The
fatty acids and /3-monoglyceride diffuse from the
micelles into the intestinal mucosa while bile acids
remain in the lumen and are absorbed by an active
process in theterminal ileum (7). Withinthe mucosal
cell, triglyceride is resynthesized and packaged with
cholesterol, cholesterol esters, and specific proteins
to form chylomicrons which leave the baso-lateral
membrane ofthe cell, enter lymphatics, and eventu-
allyjoin the blood via the thoracic duct (8, 9). Diges-
tion and absorption ofcarbohydrates and proteins is
less complex (8). Pancreatic amylase hydrolyzes
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Food Amount Form
Fat 100 g 95% triglycerides
5% other
Carbohydrates 350 g 50%o starch
35% disaccharides
10%o monosaccharides
5% fiber
Protein 75 g mixed proteins
Other few g vitamins, minerals
Water 2300 ml
starch only to maltose and small oligosaccharides
(10). These products plus ingested disaccharides,
primarily lactose and sucrose, are furthercleaved to
monosaccharides by disaccharidases in the brush
border membrane ofthe epithelial cells. In contrast,
approximately l/ to ½2 of the ingested protein is
hydrolyzed completely to free amino acids by pan-
creaticenzymes. Whatremains ispeptidesaveraging
2 to 6 amino acids in length which are cleaved by
peptide hydrolases while being transported through
the epithelial cells. Peptide hydrolases are present
notonlyinthebrushbordermembranebutalsointhe
cytosol and it is clear that some peptide molecules
are transported intact and hydrolyzed inside the cell
(11).
The quantities of nutrients ingested (Table 1) are
farless than the digestive-absorptive capacity ofthe
intestine. Although fecal fat does increase slightly
with increasing amounts of fat ingested, normal
subjects are capable ofabsorbing more than 350 gof
fatdaily (12). The reserve capacity forcarbohydrate
and protein is even greater than for fat. Reserve
capacity is in part due to excess function, including
9-to 10-fold morepancreatic enzyme activity (13), 2-
to 3-fold higher bile salt concentration (2, 7), and
severalfold more surface area, at least for protein
and carbohydrate (14), than the minimum required
for normal absorption. Adaptation also contributes
to the reserve capacity of the intestine. Thus, fol-
lowingresection orby-pass ofpartofthe small intes-
tine the remaining segment undergoes changes in
enzyme activity and morphology and an increase in
absorbing capacity percentimeteroflength-(15, 16).
Also, resection or disease of the terminal ileum
which results in excessive fecal losses of bile acids
induces anincrease in bile acid synthesis by the liver
of up to 10-fold the normal rate (7). The digestive
system can alsopartially compensatefortotal loss of
pancreatic secretions (17, 18). Although this reserve
absorptive capacity is of obvious benefit it often
precludes early detection of conditions that cause
malabsorption or detection of slight damage.
The malabsorption syndrome, i.e., steatorrhea
and weight loss, is caused by many diseases which
canbeconvenientlydivided intogroupsbasedonthe
major deficiency leading to the absorptive defect
(Table 3) (1, 2). Most ofthese diseases cause malab-
sorption of many or all nutrients. There are other
diseases which cause malabsorption ofonly one or a
few related nutrients and which do not produce the
malabsorption syndrome. The most important of
these are categorized in Table 4 (19).
Although a great many tests have been proposed
fordetecting anddiagnosing the cause ofmalabsorp-
tion, many of them are only different methods of
gathering the same information. Therefore, a ra-
tional approach to investigation ofsuspected malab-
sorption need notinvolve alarge numberoftests. By
history, most patients with malabsorption have
diarrheaandweightloss, butoccasionally thepatient
will complain predominantly of one or more other
Table 2. Steps in digestion and absorption of fats.
Intestinal lumen Epithelial cell
Pancreas Liver Brush border Cytosol Lymphatics Blood
Digestion Micellar Digestion-absorption
solubilization
fatty acids triglycerides
Triglycerides - + * mixed micelles. absorption -* then - * -
,8-monoglyceride chylomicrons
Carbohydrates
oligosaccharides
Starch - + o monosaccharides
disaccharides
Disaccharides * monosaccharides
oligopeptides
Protein + 0 amino acids
amino acids
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Insufficient pancreatic enzyme activity
Chronic pancreatitis
Pancreatic carcinoma
Pancreatic resection
Cystic fibrosis
Enterokinase deficiency
Isolated lipase deficiency
Insufficient bile acid
Extrahepatic biliary obstruction
Intrahepatic biliary obstruction
Intestinal stasis syndromes
Disease of the small intestinal wall
Celiac sprue
Tropical sprue
Whipple's disease
Infiltrative disease-amyloid, lymphoma
Small bowel ischemia - athrosclerosis, vasculitis
Jejunal resection
Intestinal lymphangiectasia
a-B-Lipoproteinemia
Multiple defects
Gastrin-secreting tumor
Scleroderma
Ileal dysfunction - resection, disease
Steatorrhea following gastric surgery
Radiation enteritis
Mechanism unknown
Mast cell disease
Immune deficiencies
Carcinoid
Diabetes mellitus
Hyperthyroidism
Adrenal insufficiency
Parasitic infections (giardiasis, strongyloidiasis)
Drugs
Colchicine
Cholestyramine
p-Aminosalicylate
Cathartics
Neomycin
Alcohol
Clofibrate
Phenindione
symptoms including weakness, bleeding tendency,
sore tongue, tetany, bone pain, edema, amenorrhea,
or peripheral neuritis. The physical exam is often
unremarkable but may show signs ofmalnutrition or
of specific vitamin deficiencies.
Since most patients who present with these
symptoms and signs will not have malabsorption,
appropriate tests must be done to rule out the other
more common conditions including intestinal can-
cers, inflammatory bowel disease, and infectious
diarrheas.
Initial procedures to investigate malabsorption
generally include visual inspection of the stool, ex-
amination of the stool for meat fibers (20), and
semiquantitative determination of fecal fat by
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counting microscopic lipid droplets after treatment
ofa stool specimen withafat stain such as sudan (20,
21). Initial blood studies include carotenoids and
folic acid. Since these compounds are not syn-
thesized or stored by humans in appreciable quan-
tities, the blood levels fall when absorption de-
creases if intake remains constant. However, low
folate and carotenoid levels are not specific for
malabsorption. Prothrombin time or serum alkaline
phosphatase activity may be abnormal when vitamin
K or vitamin D and calcium absorption, respec-
tively, have beendecreased fora longperiod oftime.
Blood levels of calcium, magnesium, phosphorus,
cholesterol, and vitamin B12 may also be obtained,
but the results are often normal or only slightly de-
creased even when malabsorption is clinically obvi-
ous. Plain radiographs of the abdomen and barium
contrast studies of the upper gastrointestinal tract
and small bowel are performed to look for evidence
of pancreatic or small bowel disease.
Sincethedigestion-absorptionoffatrequires more
stepsandhasless reservecapacitythanthatforother
nutrients, quantitative analysis ofstool fat in a 72-hr
collection is the most definitive test for malabsorp-
tion. The patient must be ingesting aknown quantity
offat, greater than 50 g/day and preferably close to
100g/day, beginning at least 48 hrbefore starting the
collection. Accuracy of the test depends on careful
stool collection and estimation of fat intake, avoid-
ance ofdrugs that alter intestinal motility, barium, or
other agents that interfere with the assay and cathar-
tics or other suppositories that add fat to the stool,
and a properly performed assay.
Table 4. Diseases which cause malabsorption ofonly one or a few
related nutrients.
Primary disaccharidase deficiency
Acquired lactase deficiency
Congenital lactase deficiency
Congenital sucrase-isomaltase deficiency
Monosaccharide malabsorption
Glucose malabsorption
Fructose malabsorption
Amino acid malabsorption
Cystinuria
Hartnup's disease
Methionine malabsorption
Proline malabsorption
Vitamin B12 malabsorption
Pernicious anemia
Congenital B12 malabsorption
Alcohol
Folic acid malabsorption
Oral contraceptives
Dilatin
Alcohol
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tion has been developed, namely the 14C-triolein
breath test (22). Triolein labeled with 14C in the car-
boxyl group is given orally, and the percent of ad-
ministered label expired as 14CO2 over the next 6 hr
is determined. Constant collection of the expired
C02 iS possible but impractical. Instead a known
quantity ofthe C02 is collected in hyamine at inter-
vals and its specific activity is determined by scintil-
lation counting. The total label expired in 6 hris then
calculated byassuming aconstantC02 production of
9 mmole/kg-hr for the patient at rest. The initial
report (22) which indicates that this test is as sensi-
tive and specific for fat malabsorption as the 72-hr
fecalfat assay requires confirmation. The breath test
can also be done by using 13C-triolein, avoiding a
radioactive label (23).
The D-xylose test is frequently used in evaluating
intestinal absorption (24, 25). D-Xylose is a five-
carbon sugar that is absorbed by the intestinal mu-
cosa and requires no intraluminal digestion. It is
poorly metabolized inthe body and isexcreted intact
in the urine. After an oral dose, urine is collected for
5 hr and assayed colorimetrically for D-xylose. Nor-
mally, 20% or more ofthe ingested dose is present in
thisurine specimen. Determinationofblood levels of
D-xylose 30 to 60 min following the dose may add
significantly to theaccuracy ofthe test. Lowerlevels
suggest a decrease in effective mucosal surface area
or intestinal stasis in which bacteria metabolize the
D-xylose before it can be absorbed. There are many
causes offalsely low test results and occasional pa-
tients with documented mucosal disease have nor-
mal test results. For these reasons the test may
eventually fall into disuse in favor of proceeding
directly toperoral intestinal biopsyforevaluatingthe
intestinal mucosa (26).
Peroral biopsy of the intestinal mucosa is a safe,
relatively simple procedure (27). Depending on the
instrument used, one to four pieces oftissue can be
obtained with a total weight of up to approximately
35 mg. A hydraulic instrument is available for re-
search purposes which will permit repeated biopsies
from the same patient at different levels ofthe small
intestine without having to repeatedly remove and
re-insert the instrument (28). Biopsy specimens are
used for many types of study including light and
electron microscopic examination, chemical and en-
zymatic assays, tissue culture, anduptake ofvarious
radiolabeled compounds.
There are a few other useful tests of intestinal
function. Pancreatic secretory tests are used in
which a tube is passed by mouth into the duodenum
whereby secretions from the pancreas can be aspi-
rated. The pancreas is then stimulated to secrete
either by injecting the hormone secretin orby giving
a standard meal and the volume, composition, and
enzyme activity of the secreted pancreatic fluid is
measured and compared with established normal
values (29). The Schilling test determines B12 ab-
sorption by measurement of radiolabeled Bl2 ex-
creted in the urine for 24 hr following an oral dose
(30). A large dose of nonlabeled vitamin is given
parenterally to saturatetissue-binding sites. Intrinsic
factornormally secretedby the stomach is necessary
for B12 absorption so if the initial (first stage) test is
abnormal the test must be repeated, this time giving
intrinsic factor with the oral Bl2 (second stage). An
abnormal second stage test indicates either dysfunc-
tion of the terminal ileum, where B12 is actively
absorbed, or intestinal stasis as the bacteria in this
condition may take up and bind B12 before it can be
absorbed.
Excessive loss ofwhole protein from the intestine
can be measured by giving 51Cr albumin intraven-
ously and measuring fecal radioactivity for several
days. Chromium is practically nonabsorbable, so
any that leaks out into the intestinal lumen attached
to albumin will remain and be passed in the stool
even though the protein is digested and absorbed
(31).
Breath tests similar to the triolein test already
described have been reported for detecting malab-
sorption or metabolism ofother compounds labeled
with 13C or 14C including bile acids, D-xylose, and
aminopyrine (32-34). When the bile acid cholyl-
glycinelabeledwith 14C intheglycinemoietyisgiven
orally to normal subjects most of the compound is
absorbed intact in the terminal ileum and enters the
enterohepatic circulation so relatively little is
metabolized. Ifthe bile acid comes in contact with a
large population of anerobic bacteria deconjugation
may occur, and the released glycine is metabolized
to 14CO2 which is absorbed by the intestine and
expired in the breath. Thus, either ileal dysfunction,
which causes the bile acid to escape into the colonin
excess quantities, or intestinal stasis in which col-
onic type bacteria overgrow in the upper intestine
will cause excessive quantitites of 14CO2 to be ex-
pired following administration of the labeled bile
acid. The two conditions can be distinguished by
measuring fecal radioactivity, which is elevated in
the case of ileal dysfunction but not in intestinal
stasis.
Finally, several new, apparently useful tests for
malabsorption ofvarious carbohydrates make use of
measurement of hydrogen in the breath following
ingestion ofthe test carbohydrate (35, 36). Bacteria,
but not mammalian cells, produce hydrogen during
metabolism of sugars. Hydrogen produced in the
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the intestinal tract and expired in the breath. There-
fore, the presence of significant amounts of hy-
drogen in the breath following ingestion of any
carbohydrate indicates that bacteria are coming in
contact with the compound. Normally, ordinary
doses of compounds such as lactose, sucrose, and
glucose are 100%o absorbed. Therefore, increased
breath hydrogen following their ingestion indicates
malabsorption or bacterial overgrowth in the upper
intestine. On the other hand, lactulose is a sugarthat
is not absorbed by humans, so that the time of ap-
pearance of hydrogen in the breath following its in-
gestion has been used to measure intestinal transit
time as well as bacterial overgrowth.
In summary, although absorption is the main
function of the intestine the system has a large re-
serve capacity so that most of the tests currently
used are not likely to detect early or mild changes.
Measurements done on peroral intestinal biopsies
and possibly some of the developing breath tests
offer more senstive methods for detecting intestinal
dysfunction.
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